It has been about a month since the last earnings report for Mondelez (MDLZ). Shares have lost about 2.2% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Mondelez due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
How Have Estimates Been Moving Since Then?
It turns out, estimates revision have trended upward during the past month.
VGM Scores
At this time, Mondelez has a nice Growth Score of B, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Mondelez has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
Mondelez is part of the Zacks Food - Miscellaneous industry. Over the past month, Medifast (MED), a stock from the same industry, has gained 2.6%. The company reported its results for the quarter ended March 2025 more than a month ago.
Medifast reported revenues of $115.73 million in the last reported quarter, representing a year-over-year change of -33.8%. EPS of -$0.11 for the same period compares with $0.66 a year ago.
For the current quarter, Medifast is expected to post break-even earnings per share, indicating a change of -100% from the year-ago quarter. The Zacks Consensus Estimate has changed +100% over the last 30 days.
Medifast has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Mondelez International, Inc. (MDLZ): Free Stock Analysis Report MEDIFAST INC (MED): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
